Evidence map›Paper›PMID 25118270›Full record

ArticleThe Journal of antimicrobial chemotherapy2014

Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108,717 clinical isolates from primary, secondary and tertiary care patients in London.

Luke S P Moore, Rachel Freeman, Mark J Gilchrist, Myriam Gharbi, Eimear T Brannigan, Hugo Donaldson, David M Livermore, Alison H Holmes

Abstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Spread of Carbapenem-ResistantMicroorganisms · 2019
    Article
  15. Emergence of antibiotic resistanceGenes & diseases · 2019
    Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Luke S P MooreNational Centre for Infection Prevention and Management, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0HS, UK Imperial College Healthcare NHS Trust, Fulham Palace Road, London W6 8RF, UK.
Rachel FreemanNational Centre for Infection Prevention and Management, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0HS, UK.
Mark J GilchristNational Centre for Infection Prevention and Management, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0HS, UK Imperial College Healthcare NHS Trust, Fulham Palace Road, London W6 8RF, UK.
Myriam GharbiNational Centre for Infection Prevention and Management, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0HS, UK.
Eimear T BranniganImperial College Healthcare NHS Trust, Fulham Palace Road, London W6 8RF, UK.
Hugo DonaldsonImperial College Healthcare NHS Trust, Fulham Palace Road, London W6 8RF, UK.
David M LivermoreNorwich Medical School, University of East Anglia, Norwich NR4 7TJ, UK Antimicrobial Resistance & Healthcare Associated Infection Reference Unit, Public Health England, 61 Colindale Avenue, London NW9 5EQ, UK.
Alison H HolmesNational Centre for Infection Prevention and Management, Imperial College London, Hammersmith Campus, Du Cane Road, London W12 0HS, UK Imperial College Healthcare NHS Trust, Fulham Palace Road, London W6 8RF, UK alison.holmes@imperial.ac.uk.

Funding

Medical Research Council G0800777
6 · The paper itself

Abstract

objectivesWe examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community.

methodsLaboratory and pharmacy information management systems were interrogated, with antimicrobial use and susceptibilities analysed between hospitals, within hospitals and over time.

resultsA total of 108,717 isolates from 71,687 patients were identified, with significant differences (at P < 0.05) in antimicrobial susceptibility between and within hospitals. Across the 4 years, rates of ESBL-/AmpC-producing Enterobacteriaceae ranged from 6.4% to 10.7% among community isolates, 17.8% to 26.9% at ward level and 25.2% to 52.5% in critical care. Significant variations were also demonstrated in glycopeptide-resistant enterococci (ward level 6.2%-17.4%; critical care 21.9%-56.3%), MRSA (ward level 18.5%-38.2%; critical care 12.5%-47.9%) and carbapenem-resistant Pseudomonas spp. (ward level 8.3%-16.9%; critical care 19.9%-53.7%). Few instances of persistently higher resistance were seen between the hospitals in equivalent cohorts, despite persistently higher antimicrobial use in Hospital 1 than Hospital 2. We found significant fluctuations in non-susceptibility year on year across the cohorts, but with few persistent trends.

conclusionsThe marked heterogeneity of antimicrobial susceptibilities between hospitals, within hospitals and over time demands detailed, standardized surveillance and appropriate benchmarking to identify possible drivers and effective interventions. Homogeneous antimicrobial policies are unlikely to continue to be suitable as individual hospitals join hospital networks, and policies should be tailored to local resistance rates, at least at the hospital level, and possibly with finer resolution, particularly for critical care.

Indexed as

Drug Resistance, BacterialAdolescentAdultAgedAged, 80 and overAnti-Bacterial AgentsBacteriaBacterial InfectionsCohort StudiesDrug TherapyFemaleHealth PolicyHospitals, TeachingHumansLondonMaleAnti-Bacterial Agentsantibiogramsantimicrobial stewardshiphealthcare-associated infectionsmultidrug-resistant organisms

Identifiers

PMID25118270
PMCPMC4228780

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.